New triarylpyrazoles as broad-spectrum anticancer agents: Design, synthesis, and biological evaluation

被引:25
作者
El-Gamal, Mohammed I. [1 ,2 ,3 ]
Park, Yi Seul [1 ,4 ]
Chi, Dae Yoon [4 ]
Yoo, Kyung Ho [5 ]
Oh, Chang-Hyun [1 ,2 ]
机构
[1] Korea Inst Sci & Technol, Ctr Biomat, Seoul 130650, South Korea
[2] Univ Sci & Technol, Dept Biomol Sci, Taejon 305333, South Korea
[3] Univ Mansoura, Fac Pharm, Dept Med Chem, Mansoura 35516, Egypt
[4] Sogang Univ, Dept Chem, Seoul 121742, South Korea
[5] Korea Inst Sci & Technol, Chem Kin Res Ctr, Seoul 130650, South Korea
关键词
Anticancer; Cytotoxicity; Diarylurea; Diarylamide; 1,3,4-Triarylpyrazole; MELANOMA-CELL LINE; ANTIPROLIFERATIVE ACTIVITY; 1,3,4-TRIARYLPYRAZOLE SCAFFOLD; DERIVATIVES; DIARYLAMIDES; DIARYLUREAS; DISCOVERY;
D O I
10.1016/j.ejmech.2013.04.067
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of diarylureas and diarylamides possessing 1,3,4-triarylpyrazole scaffold was designed and synthesized. Their in vitro antiproliferative activities against NCI-60 cell line panel were tested. Most of the compounds showed strong and broad-spectrum antiproliferative activities. Compound 18 exerted sub-micromolar IC50 values over all the subpanels of nine different cancer types. Its IC50 value over MDA-MB-435 melanoma cell line was 27 nM. Compounds 10-13, 22, and 23 possessing urea spacer exerted lethal effect over the NCI-60 panel with mean %inhibitions more than 100% in single-dose testing. Compounds 13 and 23 with urea linker and 3',5'-bis(trifluoromethyl)phenyl terminal ring showed the highest mean %inhibition over the NCI-60 panel in single-dose testing, and showed high potencies and broad-spectrum anticancer activities in five-dose testing. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 21 条
  • [1] Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
    Capdeville, R
    Buchdunger, E
    Zimmermann, J
    Matter, A
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) : 493 - 502
  • [2] Synthesis and Antiproliferative Activity of New Aminoisoquinolinylurea Derivatives against Melanoma Cell Line
    Cho, Hye Jung
    El-Gamal, Mohammed I.
    Oh, Chang-Hyun
    Lee, So Ha
    Kim, Garam
    Hong, Jun Hee
    Choi, Hong Seok
    Yoo, Kyung Ho
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (11): : 3635 - 3639
  • [3] Design, Synthesis, and Preliminary Cytotoxicity Evaluation of New Diarylureas and Diarylamides Possessing 1,3,4-Triarylpyrazole Scaffold
    Choi, Won-Kyoung
    El-Gamal, Mohammed I.
    Choi, Hong Seok
    Hong, Jun Hee
    Baek, Daejin
    Choi, Kihang
    Oh, Chang-Hyun
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (09) : 2991 - 2998
  • [4] New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies
    Choi, Won-Kyoung
    El-Gamal, Mohammed I.
    Choi, Hong Seok
    Baek, Daejin
    Oh, Chang-Hyun
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (12) : 5754 - 5762
  • [5] Choi WK, 2009, B KOREAN CHEM SOC, V30, P2027
  • [6] SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 2-(4-CHLORO-3-HYDROXYPHENYL)ETHYLAMINE AND N,N-DIALKYL DERIVATIVES AS DOPAMINE RECEPTOR LIGANDS
    CLAUDI, F
    GIORGIONI, G
    DISTEFANO, A
    ABBRACCHIO, MP
    PAOLETTI, AM
    BALDUINI, W
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) : 4408 - 4414
  • [7] Design and Synthesis of an Anticancer Diarylurea Derivative with Multiple-Kinase Inhibitory Effect
    El-Gamal, Mohammed I.
    Oh, Chang-Hyun
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (05) : 1571 - 1576
  • [8] Design, Synthesis, and Antiproliferative Activity of 3,4-Diarylpyrazole-1-carboxamide Derivatives Against Melanoma Cell Line
    El-Gamal, Mohammed I.
    Choi, Hong Seok
    Cho, Hae-Guk
    Hong, Jun Hee
    Yoo, Kyung Ho
    Oh, Chang-Hyun
    [J]. ARCHIV DER PHARMAZIE, 2011, 344 (11) : 745 - 754
  • [9] Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines
    El-Gamal, Mohammed I.
    Jung, Myung-Ho
    Lee, Woong San
    Sim, Taebo
    Yoo, Kyung Ho
    Oh, Chang-Hyun
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (08) : 3218 - 3226
  • [10] Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2
    Jung, Myung-Ho
    El-Gamal, Mohammed I.
    Abdel-Maksoud, Mohammed S.
    Sim, Taebo
    Yoo, Kyung Ho
    Oh, Chang-Hyun
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) : 4362 - 4367